Loading clinical trials...
Loading clinical trials...
Clinical Study on the Safety and Effectiveness of CLL1 CAR-T Cells in the Treatment of CLL1-positive Hematological Malignancies
Conditions
Interventions
CLL1 CAR T-cells
Locations
2
China
The first affiliated hospital of medical college of zhejiang university
Hangzhou, Zhejiang, China
The First Hospital of Zhejiang Medical Colleage Zhejiang University
Hangzhou, Zhejiang, China
Start Date
February 28, 2022
Primary Completion Date
November 30, 2024
Completion Date
November 30, 2024
Last Updated
February 23, 2022
NCT06973668
NCT03050268
NCT05735717
NCT07500441
NCT05756777
NCT06834282
Lead Sponsor
Zhejiang University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions